Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Revenue (2017 - 2025)

Historic Revenue for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to $143000.0.

  • Crinetics Pharmaceuticals' Revenue changed N/A to $143000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 4773.82%. This contributed to the annual value of $1.0 million for FY2024, which is 7410.91% down from last year.
  • Latest data reveals that Crinetics Pharmaceuticals reported Revenue of $143000.0 as of Q3 2025.
  • Crinetics Pharmaceuticals' Revenue's 5-year high stood at $3.1 million during Q1 2022, with a 5-year trough of $143000.0 in Q3 2025.
  • Its 5-year average for Revenue is $954000.0, with a median of $640000.0 in 2024.
  • As far as peak fluctuations go, Crinetics Pharmaceuticals' Revenue crashed by 7611.05% in 2024, and later soared by 15839.6% in 2025.
  • Quarter analysis of 5 years shows Crinetics Pharmaceuticals' Revenue stood at $1.1 million in 2021, then crashed by 34.23% to $709000.0 in 2022, then plummeted by 51.2% to $346000.0 in 2023, then grew by 15.32% to $399000.0 in 2024, then plummeted by 64.16% to $143000.0 in 2025.
  • Its last three reported values are $143000.0 in Q3 2025, $1.0 million for Q2 2025, and $361000.0 during Q1 2025.